But regulations remain unclear for companies that supply treatments.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Regenerative medicine in China: main progress in different fields
Military Medical Research Open Access 19 August 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Related external links
Ministry of Health/Announcement of new regulations (in Chinese)
Rights and permissions
About this article
Cite this article
Cyranoski, D. Stem-cell therapy faces more scrutiny in China. Nature 459, 146–147 (2009). https://doi.org/10.1038/459146a
Published:
Issue Date:
DOI: https://doi.org/10.1038/459146a
This article is cited by
-
Regenerative medicine in China: main progress in different fields
Military Medical Research (2016)
-
Chinese Newspaper Coverage of (Unproven) Stem Cell Therapies and their Providers
Stem Cell Reviews and Reports (2013)
-
The unregulated commercialization of stem cell treatments: a global perspective
Frontiers of Medicine (2011)
-
Order from chaos
Nature (2010)
-
Stem-cell laws in China fall short
Nature (2010)